Murat Dizbay
Overview
Explore the profile of Murat Dizbay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
464
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yildiz Y, Yasar E, Ozturk E, Karakan M, Helvaci O, Ozger H, et al.
J Med Virol
. 2024 Oct;
96(11):e70030.
PMID: 39465901
We aimed to investigate the immune responses to homologous and heterologous COVID-19 booster vaccinations in renal transplant recipients (RTRs) and to identify factors affecting these responses. In this prospective multicenter...
2.
Ozger H, Corbacioglu S, Boyaci-Dundar N, Yildiz M, Helvaci O, Altin F, et al.
Infect Dis Clin Microbiol
. 2024 Oct;
6(3):206-215.
PMID: 39399744
Objective: This study aimed to investigate the relationship between procalcitonin (PCT) kinetic and estimated glomerular filtration rates (eGFR) in critically ill patients who had Gram-negative primary bloodstream infection (GN-BSI) and...
3.
Yildiz M, Buyukkoruk M, Arslan S, Gokalp U, Bostanci H, Dikmen K, et al.
Iran J Microbiol
. 2024 Sep;
16(4):484-489.
PMID: 39267935
Background And Objectives: This study aimed to evaluate the frequency of multidrug-resistant (MDR) bacteria in biliary samples, MDR-bacteria risk factors, and the relationship between MDR-bacteria positivity and some clinical outcomes....
4.
Aysert-Yildiz P, Kalkanci A, Erdogan M, Ozger H, Ozturk A, Guzel-Tunccan O, et al.
J Photochem Photobiol B
. 2024 Sep;
260:113026.
PMID: 39243746
Background/aim: This experimental study aimed to examine the effectiveness of transdermal antimicrobial photodynamic therapy (APDT) with and without antimicrobial lock therapy (ALT), on catheter biofilms. Methods: S. epidermidis and C....
5.
Polymyxin B vs. colistin: the comparison of neurotoxic and nephrotoxic effects of the two polymyxins
Aysert-Yildiz P, Ozgen-Top O, Senturk A, Kanik S, Ozger H, Dizbay M
BMC Infect Dis
. 2024 Aug;
24(1):862.
PMID: 39187812
Background: The study aimed to compare polymyxin B with colistimethate sodium (CMS) regarding neurotoxicity, nephrotoxicity and 30-day mortality in patients with MDR Gram-negatives. Methods: All adult patients who received polymyxin...
6.
Aysert-Yildiz P, Yildiz Y, Habibi H, Eser S, Ozgen-Top O, Ozger H, et al.
Infect Dis Clin Microbiol
. 2024 Apr;
4(4):258-267.
PMID: 38633723
Objective: There are many difficulties in diagnosing and treating bacteremia. In this study, we aimed to evaluate "true" and "false-positive bacteremia" and assess mortality risk factors and the impact of...
7.
Yasar E, Yildiz Y, Ozturk E, Oguz E, Coskun Yenigun E, Ozturk R, et al.
Nephrology (Carlton)
. 2024 Mar;
29(7):405-414.
PMID: 38485143
Aim: To evaluate the vaccine response and the effect of the booster dose on COVID-19 positivity in haemodialysis (HD) and peritoneal dialysis (PD) patients who received and did not receive...
8.
Yildiz Y, Ozturk Sahin B, Demir M, Demir S, Ciftci B, Kokturk N, et al.
Tuberk Toraks
. 2023 Sep;
71(3):261-272.
PMID: 37740629
Introduction: Long COVID is a multisystem disease with various symptoms and risk factors. We aim to investigate the post-acute sequelae of COVID-19 and related risk factors in a tertiary care...
9.
Cifci B, Yildiz Y, Altin E, Habibi H, Kocer B, Dizbay M
J Neurovirol
. 2023 Feb;
29(1):111-115.
PMID: 36795262
Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system caused by reactivation of the polyomavirus JC (JCV). Human immunodeficiency virus (HIV) infection is one of...
10.
Erbay K, Ozger H, Tunccan O, Gaygisiz U, Buyukkoruk M, Sultanova F, et al.
Antimicrob Steward Healthc Epidemiol
. 2022 Dec;
2(1):e117.
PMID: 36483344
[This corrects the article DOI: 10.1017/ash.2021.254.].